Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
5 Years
7.7
93.01%
80%
—
14x
Every year
—
5 Years
Score7.7
Net Growth93.01%
Net Trend80%
Net Income Consistency—
Rev Growth14x
Rev TrendEvery year
Revenue Consistency—
Immunocore Holdings Ltd fundamental performance
Between 2021 and 2025, revenue grew from £ 27M to £ 297M and net income went from -£ 133M to -£ 26M. Revenue increased in 100% of the years measured; net income in 80%.
Immunocore Holdings Ltd currently holds a 5-year HDB Score of 7.7 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 34.74 | — |
1 Year2025-08-12 | $ 31.87 | 9.01% |
5 Years2021-08-12 | $ 30.90 | 12.43% |
All Time2021-02-05 | $ 43.20 | -19.58% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | All Time2021-02-05 |
|---|---|---|---|---|
| Price | $ 34.74 | $ 31.87 | $ 30.90 | $ 43.20 |
| Return | — | 9.01% | 12.43% | -19.58% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | £ 403M | -£ 9M | £ 880M |
| 2025 | £ 297M | -£ 26M | £ 864M |
| 2024 | £ 247M | -£ 40M | £ 820M |
| 2023 | £ 197M | -£ 43M | £ 442M |
| 2022 | £ 144M | -£ 43M | £ 402M |
| IPO2021 | £ 27M | -£ 133M | £ 321M |
Explore beyond IMCR
You're looking at Immunocore Holdings Ltd. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
